Know How Nexletol Stacks Up to Other Non-Statins

April 2020

You'll hear buzz about Nexletol (NEKS-leh-tol, bempedoic acid), a new oral non-statin cholesterol med.

Nexletol is the first ATP-citrate lyase inhibitor...blocking an earlier step of cholesterol synthesis in the liver than statins.

It's approved for patients with familial hypercholesterolemia or CV disease who need more LDL lowering...despite max tolerated statins.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote